Search Results - "Santamato, A"

Refine Results
  1. 1

    Full daylight quantum-key-distribution at 1550 nm enabled by integrated silicon photonics by Avesani, M., Calderaro, L., Schiavon, M., Stanco, A., Agnesi, C., Santamato, A., Zahidy, M., Scriminich, A., Foletto, G., Contestabile, G., Chiesa, M., Rotta, D., Artiglia, M., Montanaro, A., Romagnoli, M., Sorianello, V., Vedovato, F., Vallone, G., Villoresi, P.

    Published in npj quantum information (08-06-2021)
    “…The future envisaged global-scale quantum-communication network will comprise various nodes interconnected via optical fibers or free-space channels, depending…”
    Get full text
    Journal Article
  2. 2

    Interacting with γ-secretase for treating Alzheimer's disease: from inhibition to modulation by Panza, F, Frisardi, V, Solfrizzi, V, Imbimbo, B P, Logroscino, G, Santamato, A, Greco, A, Seripa, D, Pilotto, A

    Published in Current medicinal chemistry (01-12-2011)
    “…Drugs currently used for the treatment of Alzheimer's disease (AD) produce limited clinical benefits, and there is no disease-modifying therapy yet available…”
    Get more information
    Journal Article
  3. 3

    Short-term effects of high-intensity laser therapy versus ultrasound therapy in the treatment of low back pain: a randomized controlled trial by Fiore, P, Panza, F, Cassatella, G, Russo, A, Frisardi, V, Solfrizzi, V, Ranieri, M, Di Teo, L, Santamato, A

    “…Low back pain (LBP) is a common musculoskeletal disorder that is highly prevalent in the general population. Management of this pathology includes numerous…”
    Get more information
    Journal Article
  4. 4

    Hyperhomocysteinemia in L-dopa treated patients with Parkinson's disease: potential implications in cognitive dysfunction and dementia? by Zoccolella, S, Lamberti, S V, Iliceto, G, Santamato, A, Lamberti, P, Logroscino, G

    Published in Current medicinal chemistry (01-09-2010)
    “…Hyperhomocysteinemia has been associated with cognitive dysfunction and dementia. The incidence of dementia in Parkinson's Disease (PD) patients is higher than…”
    Get more information
    Journal Article
  5. 5

    Topical distribution of initial paresis of the limbs to predict clinically relevant spasticity after ischemic stroke: a retrospective cohort study by Picelli, A, Tamburin, S, Dambruoso, F, Midiri, A, Girardi, P, Santamato, A, Fiore, P, Smania, N

    “…The degree of initial paresis relates to spasticity development in stroke patients. However, the importance of proximal and distal paresis in predicting…”
    Get more information
    Journal Article
  6. 6

    Management of stroke patients submitted to botulinum toxin type A therapy: a Delphi survey of an Italian expert panel of specialist injectors by Franceschini, M, Iocco, M, Molteni, F, Santamato, A, Smania, N

    “…Spasticity is a common disabling symptom of several neurological conditions including stroke. Botulinum toxin type A (BTX-A) injection represents the gold…”
    Get more information
    Journal Article
  7. 7

    Acoustic analysis of swallowing sounds: a new technique for assessing dysphagia by Santamato, Andrea, Panza, Francesco, Solfrizzi, Vincenzo, Russo, Anna, Frisardi, Vincenza, Megna, Marisa, Ranieri, Maurizio, Fiore, Pietro

    Published in Journal of rehabilitation medicine (01-07-2009)
    “…To perform acoustic analysis of swallowing sounds, using a microphone and a notebook computer system, in healthy subjects and patients with dysphagia affected…”
    Get full text
    Journal Article
  8. 8

    Safety and efficacy of incobotulinum toxin type A (NT 201-Xeomin) for the treatment of post-stroke lower limb spasticity: a prospective open-label study by Santamato, A, Micello, M F, Panza, F, Fortunato, F, Pilotto, A, Giustini, A, Testa, A, Fiore, P, Ranieri, M, Spidalieri, R

    “…In recent years, NT 201, a new botulinum toxin type A (BTX-A) free of complexing proteins, has been used for treating several movement disorders, showing…”
    Get more information
    Journal Article
  9. 9

    Severe osteoporosis treated with teriparatide in a patient affected by recessive epidermolysis bullosa dystrophica by Moretti, L, Notarnicola, A, Panella, A, Garofalo, L, Garofalo, R, Santamato, A, Moretti, B

    Published in Osteoporosis international (01-03-2011)
    “…In this work, we describe the clinical and instrumental results of our experience, the first reported in the literature, of the administration of teriparatide…”
    Get full text
    Journal Article
  10. 10

    Binding of Biotin to Streptavidin: A combined fluorescence correlation spectroscopy and time-resolved fluorescence study by Strömqvist, J., Nardo, L., Broekmans, O., Kohn, J., Lamperti, M., Santamato, A., Shalaby, M., Sharma, G., Di Trapani, P., Bondani, M., Rigler, R.

    “…The Biotin-Streptavidin complex is a widely studied system in biology and biophysics, because of its extremely strong non-covalent binding affinity. The latter…”
    Get full text
    Journal Article Conference Proceeding
  11. 11

    Dietary fatty acids, age-related cognitive decline, and mild cognitive impairment by Solfrizzi, V., Capurs, C., D’Introno, A., Colacicco, A. M., Frisardi, V., Santamato, A., Ranieri, M., Fiore, R., Vendemiale, G., Seripa, D., Pilotto, A., Capurso, A., Panza, F.

    Published in The Journal of nutrition, health & aging (01-06-2008)
    “…Currently available epidemiological evidence suggested that an increase of saturated fatty acids (SFA) could have negative effects on cognitive functions,…”
    Get full text
    Journal Article
  12. 12
  13. 13

    Treatment of upper limb spasticity after stroke: one-year safety and efficacy of botulinum toxin type A NT201 by Fiore, P, Santamato, A, Ranieri, M, Bellomo, R G, Saggini, R, Panza, F, Megna, G, Cristella, G, Megna, M

    “…A new preparation of botulinum toxin type A called NT 201, free from complexing proteins, potentially with low antigenicity has been used in the therapy of…”
    Get more information
    Journal Article
  14. 14

    Pulmonary rehabilitation for patients with bronchiectasis: case reports by Santamato, A, Ranieri, M, Panza, F, Frisardi, V, Marvulli, R, Filoni, S, Cisari, C, Fiore, P

    “…The effectiveness of pulmonary rehabilitation (PR) has been recognized in national and international guidelines and highlighted by the National Institute of…”
    Get more information
    Journal Article
  15. 15

    The use of alpha-lipoic acid (ALA), gamma linolenic acid (GLA) and rehabilitation in the treatment of back pain: effect on health-related quality of life by Ranieri, M, Sciuscio, M, Cortese, A M, Santamato, A, Di Teo, L, Ianieri, G, Bellomo, R G, Stasi, M, Megna, M

    “…The aim of this trial was to evaluate the effects of alpha-lipoic acid (ALA) and gamma-linolenic acid (GLA) and the beneficial effect of physical exercise on…”
    Get more information
    Journal Article
  16. 16

    Vascular risk factors, alcohol intake, and cognitive decline by Panza, F., Capurso, C., D’Introno, A., Colacicco, A. M., Frisardi, V., Santamato, A., Ranieri, M., Fiore, P., Vendemiale, G., Seripa, D., Pilotto, A., Capurso, A., Solfrizzi, V.

    Published in The Journal of nutrition, health & aging (01-06-2008)
    “…Since the therapeutic options currently available have demonstrated limited efficacy, the search for preventive strategies for cognitive decline and dementia…”
    Get full text
    Journal Article
  17. 17

    Source Device Independent Quantum Random Number Generator with Integrated InP Photonics by Kincaid, P. S., De Marinis, L., Montanaro, A., Santamato, A., Andriolli, N., Contestabile, G.

    “…Quantum physics may be exploited for the generation of true random numbers, important in many applications, including cryptography and scientific simulations…”
    Get full text
    Conference Proceeding
  18. 18

    Associated with intrathecal baclofen treatment and duloxetine in patients with multiple sclerosis by Ranieri, M, Putignano, P, Fiore, P, Santamato, A, Megna, G, Bellomo, R G, Cristella, G, Saggini, R, Megna, M

    “…Baclofen is now used in treatment of patients with severe spasticity secondary to neurological diseases through the direct infusion of the drug into the…”
    Get more information
    Journal Article
  19. 19

    Safety and efficacy of incobotulinumtoxinA as a potential treatment for poststroke spasticity by Santamato, Andrea

    Published in Neuropsychiatric disease and treatment (01-01-2016)
    “…Spasticity is a common disabling symptom for several neurological conditions. Botulinum toxin type A injection represents the gold standard treatment for focal…”
    Get full text
    Journal Article
  20. 20

    Botulinum Toxin Type A for the Treatment of Lower Limb Spasticity after Stroke by Santamato, Andrea, Cinone, Nicoletta, Panza, Francesco, Letizia, Sara, Santoro, Luigi, Lozupone, Madia, Daniele, Antonio, Picelli, Alessandro, Baricich, Alessio, Intiso, Domenico, Ranieri, Maurizio

    Published in Drugs (New York, N.Y.) (01-02-2019)
    “…Post-stroke lower limb spasticity impairs balance and gait leading to reduced walking speed, often increasing wheelchair use and caregiver burden. Several…”
    Get full text
    Journal Article